Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Elevated levels of C-reactive protein (CRP) are associated with increased risks of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is a causal association. METHODS: We studied 10,276 persons from a general population cohort, including 1786 in whom ischemic heart disease developed and 741 in whom ischemic cerebrovascular disease developed. We examined another 31,992 persons from a cross-sectional general population study, of whom 2521 had ischemic heart disease and 1483 had ischemic cerebrovascular disease. Finally, we compared 2238 patients with ischemic heart disease with 4474 control subjects and 612 patients with ischemic cerebrovascular disease with 1224 control subjects. We measured levels of high-sensitivity CRP and conducted genotyping for four CRP polymorphisms and two apolipoprotein E polymorphisms. RESULTS: The risk of ischemic heart disease and ischemic cerebrovascular disease was increased by a factor of 1.6 and 1.3, respectively, in persons who had CRP levels above 3 mg per liter, as compared with persons who had CRP levels below 1 mg per liter. Genotype combinations of the four CRP polymorphisms were associated with an increase in CRP levels of up to 64%, resulting in a theoretically predicted increased risk of up to 32% for ischemic heart disease and up to 25% for ischemic cerebrovascular disease. However, these genotype combinations were not associated with an increased risk of ischemic vascular disease. In contrast, apolipoprotein E genotypes were associated with both elevated cholesterol levels and an increased risk of ischemic heart disease. CONCLUSIONS: Polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a theoretically predicted increase in the risk of ischemic vascular disease. However, these polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional biomarkers, including apo B, lipoprotein(a), high-sensitivity C-reactive protein (CRP), coronary artery calcification score, and ankle-brachial index, are independent risk factors associated with increased risk of ASCVD events and may be helpful when the lipid management goal is unclear.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [284]
In the citing paper
“The value of hsCRP as a CV risk factor appears similar to that of conventional CV risk factors – hsCRP is not a causal factor for CV disease and serves as a biomarker only [36].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [36]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“Yet, despite the high CV morbidity and mortality risk, PAD patients are usually inadequately managed compared with CAD patients [511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationFasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Frikke-Schmidt, R. (2008) · JAMA · doi:10.1001/jama.299.21.2524 · Cited by 464
Carlson, C. S., Aldred, S. F., Lee, P. K., Tracy, R. P., Schwartz, S. M., Rieder, M., Liu, K., Williams, O. D., Iribarren, C., Lewis, E. C., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431366 · Cited by 324
Ballantyne, C. M., Hoogeveen, R. C., Bang, H., Coresh, J., Folsom, A. R., Chambless, L. E., Myerson, M., Wu, K. K., Sharrett, A. R., & Boerwinkle, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2479 · Cited by 280
Lange, L. A., Carlson, C. S., Hindorff, L. A., Lange, E. M., Walston, J., Durda, J. P., Cushman, M., Bis, J. C., Zeng, D., Lin, D., et al. (2006) · JAMA · doi:10.1001/jama.296.22.2703 · Cited by 266
Kathiresan, S., Larson, M. G., Vasan, R. S., Guo, C.-Y., Gona, P., Keaney, J. F., Wilson, P. W. F., Newton-Cheh, C., Musone, S. L., Camargo, A. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591271 · Cited by 231
Nitsch, D., Molokhia, M., Smeeth, L., DeStavola, B. L., Whittaker, J. C., & Leon, D. A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj062 · Cited by 227
Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events
Miller, D. T., Zee, R. Y. L., Suk Danik, J., Kozlowski, P., Chasman, D. I., Lazarus, R., Cook, N. R., Ridker, P. M., & Kwiatkowski, D. J. (2005) · Annals of Human Genetics · doi:10.1111/j.1529-8817.2005.00210.x · Cited by 220
Zee, R. Y. L., & Ridker, P. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00703-1 · Cited by 208
Schnohr, P. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2842 · Cited by 195
Self-citationSzalai, A. J., Wu, J., Lange, E. M., McCrory, M. A., Langefeld, C. D., Williams, A., Zakharkin, S. O., George, V., Allison, D. B., Cooper, G. S., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0658-0 · Cited by 181
Insight into the nature of the CRP–coronary event association using Mendelian randomization
Casas, J. P., Shah, T., Cooper, J., Hawe, E., McMahon, A. D., Gaffney, D., Packard, C. J., O'Reilly, D. S., Juhan-Vague, I., Yudkin, J. S., et al. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl041 · Cited by 172
Proinflammatory Genetic Profiles in Subjects With History of Ischemic Stroke
Flex, A., Gaetani, E., Papaleo, P., Straface, G., Proia, A. S., Pecorini, G., Tondi, P., Pola, P., & Pola, R. (2004) · Stroke · doi:10.1161/01.str.0000140740.19421.fe · Cited by 160
Serum C-Reactive Protein Concentration and Genotype in Relation to Ischemic Stroke Subtype
Ladenvall, C., Jood, K., Blomstrand, C., Nilsson, S., Jern, C., & Ladenvall, P. (2006) · Stroke · doi:10.1161/01.str.0000231872.86071.68 · Cited by 158
Everett, B. M., Kurth, T., Buring, J. E., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.030 · Cited by 149
Kovacs, A., Green, F. R., Hansson, L., Lundman, P., Samnegård, A., Boquist, S., Ericsson, C.-G., Watkins, H. C., Hamsten, A., & Tornvall, P. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.018 · Cited by 136
Sattar, N. A., Murray, H. M., McConnachie, A., Blauw, G. J., Bollen, E. L. E. M., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643114 · Cited by 130
C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study
Kardys, I., de Maat, M. P. M., Uitterlinden, A. G., Albert Hofman, D., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl018 · Cited by 97
C-reactive protein and cardiovascular disease: Weighing the evidence
Lowe, G. D. O., & Pepys, M. B. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0040-x · Cited by 93
Bis, J. C., Heckbert, S. R., Smith, N. L., Reiner, A. P., Rice, K. M., Lumley, T., Hindorff, L. A., Marciante, K. D., Enquobahrie, D. A., Monks, S. A., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.031 · Cited by 91
Frikke-Schmidt, R., Tybjærg-Hansen, A., Steffensen, R., Jensen, G., & Nordestgaard, B. G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00520-9 · Cited by 77
Self-citationSzalai, A. J., Alarcón, G. S., Alén, J. C., Toloza, S., McCrory, M. A., Edberg, J. C., McGwin, G., Bastian, H. M., Fessler, B. J., Vilá, L. M., et al. (2005) · Rheumatology · doi:10.1093/rheumatology/keh613 · Cited by 77
Wang, Q., Hunt, S. C., Xu, Q., Chen, Y. E., Province, M. A., Eckfeldt, J. H., Pankow, J. S., & Song, Q. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01164.2005 · Cited by 61
ACE Gene Polymorphism as a Risk Factor for Ischemic Cerebrovascular Disease
Agerholm-Larsen, B., Tybjærg‐Hansen, A., Frikke‐Schmidt, R., Grønholdt, M. L., Jensen, G., & Nordestgaard, B. G. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-5-199709010-00002 · Cited by 56
Self-citationCRP Gene Haplotypes, Serum CRP, and Cerebral Small-Vessel Disease
Reitz, C., Berger, K., de Maat, M. P. M., Stoll, M., Friedrichs, F., Kardys, I., Witteman, J. C. M., & Breteler, M. M. B. (2007) · Stroke · doi:10.1161/strokeaha.107.482661 · Cited by 36
Balistreri, C. R., Vasto, S., Listı̀, F., Grimaldi, M. P., Lio, D., Colonna‐Romano, G., Caruso, M., Caimi, G., Hoffmann, E., Caruso, C., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.036 · Cited by 31
Refinements of the Semiparametric Proportional Hazards Model
Klein, J. P., & Moeschberger, M. L. (2003) · Statistics for biology and health · doi:10.1007/0-387-21645-6_9 · Cited by 26
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Avoiding bias from weak instruments in Mendelian randomization studies
Burgess, S., Thompson, S. G., & CRP CHD Genetics Collaboration (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr036 · Cited by 3,952
Mendelian Randomization as an Approach to Assess Causality Using Observational Data
Sekula, P., Del Greco M, F., Pattaro, C., & Köttgen, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010098 · Cited by 2,351
Metadata
- Authors
- Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G.
- Affiliations
- University of Copenhagen (DK)
- Herlev Hospital (DK)
- Rigshospitalet (DK)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-30
- Volume
- 359
- Issue
- 18
- Pages
- 1897-1908
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2081615427
- Cited by
- 839
- References
- 36
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 21 · 2023: 21 · 2022: 26 · 2021: 25 · 2020: 33 · 2019: 25 · 2018: 28 · 2017: 40 · 2016: 48 · 2015: 44 · 2014: 61 · 2013: 56 · 2012: 76
- FWCI
- 102.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- C-reactive protein, ischemic heart disease, ischemic cerebrovascular disease, ischemic vascular disease, CRP gene polymorphisms, apolipoprotein E, high-sensitivity CRP, genetic association, cholesterol levels, causal relationship
- MeSH terms
- C-Reactive Protein, Cerebrovascular Disorders, Cross-Sectional Studies, Female, Humans, Male, Polymorphism, Genetic, Risk Factors, Cohort Studies, Biomarkers, Myocardial Ischemia, Genetic Predisposition to Disease, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.